Sanofi announces the official commercialization and listing of Leweichu in China. Today, it was learned from Sanofi that the company's long-acting monoclonal antibody Leweichu (Nisevirumab Injection) ...

This year marks the 60th anniversary of the establishment of diplomatic relations between China and France. As one of the first French medical and health enterprises to take root in China, Sanofi wil ...

On February 23rd, Sanofi announced that the US Food and Drug Administration (FDA) had granted dabitol& Reg; Priority review of the application for market authorization (sBLA) for the sixth potential ...

On January 23rd, Sanofi announced on its official website that it had reached a final agreement with biopharmaceutical listed company Inhibrx. According to the agreement, Sanofi agreed to acquire Inh ...